Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 335

    1.

    Well-being and symptoms in relation to insulin therapy in type 2 diabetes.

    de Sonnaville JJ, Snoek FJ, Colly LP, Devillé W, Wijkel D, Heine RJ.

    Diabetes Care. 1998 Jun;21(6):919-24.PMID: 9614608 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Symptoms and well-being in relation to glycemic control in type II diabetes.

    Van der Does FE, De Neeling JN, Snoek FJ, Kostense PJ, Grootenhuis PA, Bouter LM, Heine RJ.

    Diabetes Care. 1996 Mar;19(3):204-10.PMID: 8742562 [PubMed - indexed for MEDLINE]Related articles

    3.

    Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

    Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

    Diabetes Care. 1995 Aug;18(8):1113-23.PMID: 7587846 [PubMed - indexed for MEDLINE]Related articles

    4.

    Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes. Effects on well-being at 1 year.

    van der Does FE, de Neeling JN, Snoek FJ, Grootenhuis PA, Kostense PJ, Bouter LM, Heine RJ.

    Diabetes Care. 1998 Dec;21(12):2085-93.PMID: 9839098 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study.

    de Sonnaville JJ, Bouma M, Colly LP, Devillé W, Wijkel D, Heine RJ.

    Diabetologia. 1997 Nov;40(11):1334-40.PMID: 9389427 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.

    Davis TM, Clifford RM, Davis WA; Fremantle Diabetes Study.

    Diabetes Res Clin Pract. 2001 Apr;52(1):63-71.PMID: 11182217 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?

    de Grauw WJ, van de Lisdonk EH, van Gerwen WH, van den Hoogen HJ, van Weel C.

    Br J Gen Pract. 2001 Jul;51(468):527-32.PMID: 11462311 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

    Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

    Diabetes Care. 2001 Jul;24(7):1167-74.PMID: 11423497 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Treatment satisfaction after commencement of insulin in Type 2 diabetes.

    Wilson M, Moore MP, Lunt H.

    Diabetes Res Clin Pract. 2004 Dec;66(3):263-7.PMID: 15536023 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.

    Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP.

    Neth J Med. 1999 Feb;54(2):63-9.PMID: 10079680 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Associations of emotional state and quality of life with lipid concentration, duration of the disease, and the way of treating the disease in persons with type 2 diabetes mellitus]

    Lasaite L, Lasiene J, Kazanavicius G, Gostautas A.

    Medicina (Kaunas). 2009;45(2):85-94. Lithuanian. PMID: 19289898 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study.

    Adriaanse MC, Dekker JM, Spijkerman AM, Twisk JW, Nijpels G, van der Ploeg HM, Heine RJ, Snoek FJ.

    Qual Life Res. 2005 Aug;14(6):1501-9.PMID: 16110930 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

    Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Salo S, Seppälä P, Tulokas T, Viikari J, Taskinen MR.

    J Clin Endocrinol Metab. 1997 Dec;82(12):4037-43.PMID: 9398709 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

    Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

    Clin Ther. 2004 May;26(5):744-54.PMID: 15220018 [PubMed - indexed for MEDLINE]Related articles

    17.

    Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

    Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.

    Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N.

    Diabetes Care. 1996 Dec;19(12):1375-81.PMID: 8941467 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    20.

    Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group.

    Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougnères PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A.

    Diabetes Care. 1998 Jul;21(7):1146-53.PMID: 9653610 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data